Stay updated on NC318 Safety and Tolerability in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the NC318 Safety and Tolerability in Solid Tumors Clinical Trial page.

Latest updates to the NC318 Safety and Tolerability in Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe page footer now lists ClinicalTrials.gov revision v3.8.1 instead of v3.8.0. The study details appear unchanged.SummaryDifference0.1%

- Check8 days agoChange DetectedThe completed NC318 phase 1/2 trial record is now displayed, with study details, eligibility criteria, treatment arms, outcomes, locations, and results-related information, replacing a 403 error page.SummaryDifference70%

- Check15 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedA sitewide NIH notice announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision label also changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check43 days agoChange DetectedThe footer’s site revision marker changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check57 days agoChange DetectedA 403 Forbidden page is shown, replacing the study information with an error screen and a Home link, which makes the study details inaccessible.SummaryDifference21%

Stay in the know with updates to NC318 Safety and Tolerability in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NC318 Safety and Tolerability in Solid Tumors Clinical Trial page.